Nobiletin alleviates atherosclerosis by inhibiting lipid uptake via the PPARG/CD36 pathway

MLA

Heng Wang, et al. “Nobiletin Alleviates Atherosclerosis by Inhibiting Lipid Uptake via the PPARG/CD36 Pathway.” Lipids in Health and Disease, vol. 23, no. 1, Mar. 2024, pp. 1–18. EBSCOhost, https://doi.org/10.1186/s12944-024-02049-5.

APA

Heng Wang, Qinqin Tian, Ruijing Zhang, Qiujing Du, Jie Hu, Tingting Gao, Siqi Gao, Keyi Fan, Xing Cheng, Sheng Yan, Guoping Zheng, & Honglin Dong. (2024). Nobiletin alleviates atherosclerosis by inhibiting lipid uptake via the PPARG/CD36 pathway. Lipids in Health and Disease, 23(1), 1–18. https://doi.org/10.1186/s12944-024-02049-5

Chicago

Heng Wang, Qinqin Tian, Ruijing Zhang, Qiujing Du, Jie Hu, Tingting Gao, Siqi Gao, et al. 2024. “Nobiletin Alleviates Atherosclerosis by Inhibiting Lipid Uptake via the PPARG/CD36 Pathway.” Lipids in Health and Disease 23 (1): 1–18. doi:10.1186/s12944-024-02049-5.